Join the members of our Hepato-Pancreato-Biliary (HPB) Disease Site Work Group for a discussion on crucial aspects of quality care in HPB cancer surgery. Surgeons will share insights on tools and methods to enhance patient care, covering topics like quality indicators, standard requirements, operative standards, and addressing disparities.
Module 3 will review data and solutions for inequalities and inequities in receipt of guideline-concordant care and clinical trials enrolment across patient populations with vulnerabilities, as well as for disparities that may arise with centralization of surgical care.
The faculty for this activity are listed below:
Julie Hallet, MD, M.Sc., FRSC (Moderator)
Sunnybrook Health Sciences Centre
Patricio Polanco, MD (Moderator)
UT Southwestern
Teviah Sachs, MD, MPH (Presenter)
Boston University School of Medicine
Ugwuji Maduekwe, MD, MMSc, MPH, FACS, FSSO (Presenter)
Medical College of Wisconsin
Zhi Ven Fong, MD, MPH, DrPH (Presenter)
Mayo Clinic Arizona
Requirements for Earning Credit and Method of Participation
Estimated Time to Complete Activity
As required by the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all planners, reviewers, presenters, instructors, moderators, authors, and other individuals in a position to control or influence the content of an activity must disclose ALL financial relationships with any ineligible company that have occurred within the past 24 months. Ineligible companies are those that cannot be accredited in the ACCME System and whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
As the accredited provider, SSO is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships of any dollar amount are defined as relevant if the educational content is related to the business lines or products of the ineligible company.
All identified conflicts of interest must be mitigated, and the educational content vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. If you perceive bias while participating in this activity, please advise us of the circumstances when completing your postactivity evaluation form.
All identified conflicts of interests have been mitigated.
Faculty
Julie Hallet, MD, M.Sc., FRSC (Moderator/Presenter) has disclosed the following financial relationships Ipsen, Novartis, Medtronic.
Patricio Polanco, MD (Moderator/Presenter) has disclosed the following financial relationships - Palisade Bio, IOTA Bio Inc.
Teviah Sachs, MD, MPH (Presenter) has disclosed no financial relationships.
Ugwuji Maduekwe, MD, MMSc, MPH, FACS, FSSO (Presenter) has disclosed the following financial relationships - The Cigna Group - SBAS/Cigna Academic Research.
Zhi Ven Fong, MD, MPH, DrPH (Presenter) has disclosed no financial relationships.
Planners, Reviewers, and Staff
Timothy Fitzgerald, CME Committe Chair and Reviewer has disclosed no financial relationships.
Carlos HF Chan, MD, PhD, FACS, FRCSC, FSSO, CME Committee Reviewer, has disclosed the following financial relationships - Checkmate Pharmaceuticals, Regeneron Pharmaceuticals, Optimum Therapeutics, Angiodynamics.
Patti Stella, CAE, CHCP, Society of Surgical Oncology, has disclosed the following financial relationships - Horizon Therapeutics, SODR Biotech (XBI).
Meagan Gilliland-Johnson, Society of Surgical Oncology, has disclosed no financial relationships.
Devin Winkler, Society of Surgical Oncology, has disclosed no financial relationships.
The primary purpose of the Society of Surgical Oncology's internet live course is educational. Information, as well as technologies, products, and/or services, discussed are intended to inform participants about the knowledge, techniques, and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exists in the specialty, and the Society of Surgical Oncology disclaims any and all liability for damages to any individual using the materials and for all claims which may result from the use of information, technologies, products, and/or services discussed.